Shan Ahmed Khan, Author at TechStock²

Luminar Technologies (LAZR) Stock Jumps on Buyout Hopes Amid Volvo Split and Debt Crunch

As of December 4, 2025, Luminar Technologies, Inc. (NASDAQ: LAZR) is trading more like a distressed option on the future of lidar than a normal growth stock. The share price has bounced sharply intraday — up nearly 25% around midday

4 December 2025

Automotive Industry·Investment News·Mergers & Acquisitions·Stock Market·Technology

BigBear.ai (BBAI) Stock Jumps on Defense‑AI Hype: Latest Price, Forecast and Dilution Risks as of December 4, 2025

BigBear.ai Holdings, Inc. (NYSE: BBAI) is back in the spotlight. The defense‑focused artificial intelligence stock is trading near multi‑month highs after a sharp rebound driven by its Ask Sage acquisition, new international deals, and a wave of interest in “mission‑ready”

4 December 2025

Artificial Intelligence·Defense Industry·Investment News·Market Analysis·Stocks

Aurora Innovation (AUR) Stock Surges on Insider Buying and Driverless Milestones: Latest Price, News and 2026 Forecast (4 December 2025)

Updated: December 4, 2025 Key takeaways AUR stock today: rally continues into December 4, 2025 As of mid‑day trading on December 4, 2025, Aurora Innovation, Inc. (NASDAQ: AUR) is changing hands around $4.64 per share, up roughly 2–3% on the

4 December 2025

Autonomous Vehicles·Company Analysis·Financial Forecasts·Investment News·Stock Market

IonQ, Inc. (IONQ) Stock Jumps on Quantum-AI and Defense Deals: December 4, 2025 Outlook

IonQ’s stock is having another very “on‑brand” quantum day: volatile, loud, and hard to ignore. Around midday on December 4, 2025, IonQ, Inc. (NYSE: IONQ) was trading in the mid‑$50s, up double digits intraday after a string of headlines tying

4 December 2025

Artificial Intelligence·Defense Industry·Quantum Computing·Stock Market·Technology News

AST SpaceMobile (ASTS) Soars as BlueBird 6 Launch Nears: Latest News, Stock Forecasts and Analysis as of 4 December 2025

AST SpaceMobile, Inc. (NASDAQ: ASTS) is back in the spotlight. The satellite‑to‑smartphone pioneer’s share price has jumped into the low‑$70s, powered by a wave of manufacturing expansion news, a firm launch date for its next‑generation BlueBird 6 satellite, and a

4 December 2025

Company News·Financial Forecasts·Investment Analysis·Space Technology·Stock Market

EQT Corporation (EQT) Stock Hits Record High as Analysts Lift Targets – Latest News, Forecasts and 2026–2027 Outlook

PITTSBURGH — December 4, 2025 — EQT Corporation (NYSE: EQT), the largest U.S. natural gas producer, is trading near record territory after a powerful multi‑month rally driven by stronger margins, a vertically integrated gas platform and renewed optimism around LNG

4 December 2025

Analyst Forecasts·Energy Sector·Financial News·Investment·Stock Market

Accenture (ACN) Stock on December 4, 2025: AI Restructuring, OpenAI Deal and 2026 Forecasts Explained

New York, December 4, 2025 — Accenture plc (NYSE: ACN) is deep into a self‑described “reinvention” built around artificial intelligence at the same time its stock is still well below last year’s peak. On Thursday, Accenture shares were trading around

4 December 2025

Artificial Intelligence·Business Strategy·Investment Analysis·Stock Market·Technology News

Humana Stock (HUM) Outlook December 4, 2025: Earnings Beat, Legal Risks and 2026 Medicare Advantage Forecast

Date: December 4, 2025Ticker: Humana Inc. (NYSE: HUM) Humana’s share price spent most of 2025 behaving like a stressed-out cardiogram: sharp drops around guidance cuts and star-rating headlines, then sharp rebounds when the numbers looked less bad than feared. As

4 December 2025

Earnings Reports·Health Insurance·Legal Risks·Stock Market

Incannex Healthcare (IXHL) Stock Soars on FDA Fast Track: December 2025 Outlook, Forecast & Key Risks

Incannex Healthcare Inc. (Nasdaq: IXHL) is back on traders’ radar after the U.S. Food and Drug Administration granted Fast Track designation to its lead sleep-apnoea drug candidate, IHL‑42X. The move caps a busy 2025 that also brought strong Phase 2

4 December 2025

FDA News·Healthcare Stocks·Investment Forecasts·Risk Analysis·Stock Market

KALA BIO (KALA) Stock Explodes on Oxford Deal and $10M Offering: What December 4, 2025 Means for Investors

As of December 4, 2025, KALA BIO, Inc. (NASDAQ: KALA) has turned into one of the wildest tickers on the Nasdaq. The stock is trading around $1.40 in heavy volume, up roughly 50% on the day after a cascade of

4 December 2025

Biotech Stocks·Financial News·Investing·Market Analysis·Stock Market

Costco Stock (COST) in December 2025: Tariff Fight, Strong Sales and a High‑Valuation 2026 Buy Case

Costco stock sits at an odd crossroads as of December 4, 2025. Operationally, the warehouse giant is firing on almost all cylinders: sales are growing, e‑commerce is accelerating, and membership income keeps hitting records. At the same time, the company

4 December 2025

Economic Policy·Financial Analysis·Investment Strategies·Retail Industry·Stock Market

Tonix Pharmaceuticals (TNXP) Stock Today, December 4, 2025: Tonmya Launch, Buyback and $400M ATM Define a Volatile Biotech Story

As Tonix Pharmaceuticals transitions from clinical-stage hopeful to commercial biotech on the back of its new fibromyalgia drug Tonmya, Wall Street is split between blockbuster dreams and dilution fears. TNXP Stock on December 4, 2025: Price, Volume and Volatility Tonix

4 December 2025

Biotech·Company News·Investments·Pharmaceuticals·Stock Market